D
Sotera Health Company
SHC
$11.13
-$0.53-4.55%
D
Sell
3/3/2025Downgrade
Sotera Health Company (SHC) was downgraded to D from C- on 3/3/2025 due to a significant decline in the growth index, total return index and solvency index. Operating cash flow declined 42.83% from $97.45M to $55.72M, earnings per share declined from $0.06 to $0.0435, and debt to equity increased from 4.75 to 5.51.
Sotera Health Company (SHC) was downgraded to D from C- on 3/3/2025 due to a significant decline in the growth index, total return index and solvency index. Operating cash flow declined 42.83% from $97.45M to $55.72M, earnings per share declined from $0.06 to $0.0435, and debt to equity increased from 4.75 to 5.51.
C
Hold
11/22/2024Downgrade
Sotera Health Company (SHC) was downgraded to C- from C on 11/22/2024 due to a decline in the total return index and volatility index.
Sotera Health Company (SHC) was downgraded to C- from C on 11/22/2024 due to a decline in the total return index and volatility index.
C
Hold
11/7/2024Upgraded
Sotera Health Company (SHC) was upgraded to C from C- on 11/7/2024 due to a major increase in the total return index, valuation index and solvency index. Debt to equity declined from 5.28 to 4.75, and the quick ratio increased from 2.4 to 2.48.
Sotera Health Company (SHC) was upgraded to C from C- on 11/7/2024 due to a major increase in the total return index, valuation index and solvency index. Debt to equity declined from 5.28 to 4.75, and the quick ratio increased from 2.4 to 2.48.
C
Hold
8/6/2024Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/6/2024 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 531.97% from $9.7M to $61.3M, earnings per share increased from $0.02 to $0.03, and EBIT increased 41.12% from $60.88M to $85.91M.
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/6/2024 due to a significant increase in the growth index, solvency index and total return index. Operating cash flow increased 531.97% from $9.7M to $61.3M, earnings per share increased from $0.02 to $0.03, and EBIT increased 41.12% from $60.88M to $85.91M.
D
Sell
7/31/2024Upgraded
Sotera Health Company (SHC) was upgraded to D+ from D on 7/31/2024 due to an increase in the volatility index.
Sotera Health Company (SHC) was upgraded to D+ from D on 7/31/2024 due to an increase in the volatility index.
D
Sell
5/9/2024Downgrade
Sotera Health Company (SHC) was downgraded to D from D+ on 5/9/2024 due to a decline in the volatility index and total return index.
Sotera Health Company (SHC) was downgraded to D from D+ on 5/9/2024 due to a decline in the volatility index and total return index.
D
Sell
5/3/2024Downgrade
Sotera Health Company (SHC) was downgraded to D+ from C- on 5/3/2024 due to a substantial decline in the growth index, total return index and solvency index. Operating cash flow declined 91.43% from $113.12M to $9.7M, earnings per share declined from $0.1367 to $0.02, and EBIT declined 57.55% from $143.42M to $60.88M.
Sotera Health Company (SHC) was downgraded to D+ from C- on 5/3/2024 due to a substantial decline in the growth index, total return index and solvency index. Operating cash flow declined 91.43% from $113.12M to $9.7M, earnings per share declined from $0.1367 to $0.02, and EBIT declined 57.55% from $143.42M to $60.88M.
C
Hold
2/28/2024Upgraded
Sotera Health Company (SHC) was upgraded to C- from D on 2/28/2024 due to a significant increase in the growth index, total return index and efficiency index. Net income increased 383.17% from -$13.66M to $38.68M, earnings per share increased from -$0.05 to $0.1367, and operating cash flow increased 170.31% from $41.85M to $113.12M.
Sotera Health Company (SHC) was upgraded to C- from D on 2/28/2024 due to a significant increase in the growth index, total return index and efficiency index. Net income increased 383.17% from -$13.66M to $38.68M, earnings per share increased from -$0.05 to $0.1367, and operating cash flow increased 170.31% from $41.85M to $113.12M.
D
Sell
3/1/2023Downgrade
Sotera Health Company (SHC) was downgraded to D from C- on 3/1/2023 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0888 to -$1.1387, net income declined 1,374.29% from $25.09M to -$319.72M, and EBIT declined 6.18% from $79.44M to $74.53M.
Sotera Health Company (SHC) was downgraded to D from C- on 3/1/2023 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0888 to -$1.1387, net income declined 1,374.29% from $25.09M to -$319.72M, and EBIT declined 6.18% from $79.44M to $74.53M.
C
Hold
2/21/2023Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 2/21/2023 due to an increase in the total return index and volatility index.
Sotera Health Company (SHC) was upgraded to C- from D+ on 2/21/2023 due to an increase in the total return index and volatility index.
D
Sell
1/20/2023Upgraded
Sotera Health Company (SHC) was upgraded to D+ from D on 1/20/2023 due to an increase in the volatility index and efficiency index.
Sotera Health Company (SHC) was upgraded to D+ from D on 1/20/2023 due to an increase in the volatility index and efficiency index.
D
Sell
10/11/2022Downgrade
Sotera Health Company (SHC) was downgraded to D from D+ on 10/11/2022 due to a decline in the volatility index and total return index.
Sotera Health Company (SHC) was downgraded to D from D+ on 10/11/2022 due to a decline in the volatility index and total return index.
D
Sell
9/9/2022Downgrade
Sotera Health Company (SHC) was downgraded to D+ from C- on 9/9/2022 due to a decline in the volatility index and total return index.
Sotera Health Company (SHC) was downgraded to D+ from C- on 9/9/2022 due to a decline in the volatility index and total return index.
C
Hold
8/25/2022Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/25/2022 due to an increase in the volatility index and total return index.
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/25/2022 due to an increase in the volatility index and total return index.
D
Sell
8/9/2022Downgrade
Sotera Health Company (SHC) was downgraded to D+ from C- on 8/9/2022 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 2.73 to 2.76.
Sotera Health Company (SHC) was downgraded to D+ from C- on 8/9/2022 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from 2.73 to 2.76.
C
Hold
8/4/2022Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/4/2022 due to an increase in the volatility index.
Sotera Health Company (SHC) was upgraded to C- from D+ on 8/4/2022 due to an increase in the volatility index.
D
Sell
7/19/2022Downgrade
Sotera Health Company (SHC) was downgraded to D+ from C- on 7/19/2022 due to a large decline in the growth index, volatility index and solvency index. Operating cash flow declined 24.69% from $66.35M to $49.97M, EBIT declined 11.23% from $82.63M to $73.35M, and earnings per share declined from $0.12 to $0.1083.
Sotera Health Company (SHC) was downgraded to D+ from C- on 7/19/2022 due to a large decline in the growth index, volatility index and solvency index. Operating cash flow declined 24.69% from $66.35M to $49.97M, EBIT declined 11.23% from $82.63M to $73.35M, and earnings per share declined from $0.12 to $0.1083.
C
Hold
3/4/2022Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 3/4/2022 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 31.17% from $27.44M to $36M, earnings per share increased from $0.0982 to $0.12, and EBIT increased 12.15% from $73.68M to $82.63M.
Sotera Health Company (SHC) was upgraded to C- from D+ on 3/4/2022 due to a major increase in the growth index, valuation index and efficiency index. Net income increased 31.17% from $27.44M to $36M, earnings per share increased from $0.0982 to $0.12, and EBIT increased 12.15% from $73.68M to $82.63M.
D
Sell
11/22/2021Downgrade
Sotera Health Company (SHC) was downgraded to D+ from C- on 11/22/2021 due to a noticeable decline in the total return index and volatility index.
Sotera Health Company (SHC) was downgraded to D+ from C- on 11/22/2021 due to a noticeable decline in the total return index and volatility index.
C
Hold
11/15/2021Downgrade
Sotera Health Company (SHC) was downgraded to C- from C on 11/15/2021 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $0.15 to $0.0982, EBIT declined 19.2% from $90.76M to $73.34M, and total revenue declined 10.22% from $251.92M to $226.16M.
Sotera Health Company (SHC) was downgraded to C- from C on 11/15/2021 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $0.15 to $0.0982, EBIT declined 19.2% from $90.76M to $73.34M, and total revenue declined 10.22% from $251.92M to $226.16M.
C
Hold
11/8/2021Upgraded
Sotera Health Company (SHC) was upgraded to C from C- on 11/8/2021 due to a noticeable increase in the total return index, volatility index and solvency index.
Sotera Health Company (SHC) was upgraded to C from C- on 11/8/2021 due to a noticeable increase in the total return index, volatility index and solvency index.
C
Hold
9/28/2021Upgraded
Sotera Health Company (SHC) was upgraded to C- from D+ on 9/28/2021 due to a noticeable increase in the efficiency index, growth index and volatility index. Net income increased 292.91% from $10.84M to $42.6M, earnings per share increased from $0.0383 to $0.15, and EBIT increased 88.93% from $48.04M to $90.76M.
Sotera Health Company (SHC) was upgraded to C- from D+ on 9/28/2021 due to a noticeable increase in the efficiency index, growth index and volatility index. Net income increased 292.91% from $10.84M to $42.6M, earnings per share increased from $0.0383 to $0.15, and EBIT increased 88.93% from $48.04M to $90.76M.
D
Sell
5/17/2021Upgraded
Sotera Health Company (SHC) was upgraded to D+ from D on 5/17/2021 due to a significant increase in the growth index, efficiency index and total return index. Operating cash flow increased 157.08% from $21.85M to $56.16M, net income increased 124.82% from -$43.68M to $10.84M, and earnings per share increased from -$0.1723 to $0.0383.
Sotera Health Company (SHC) was upgraded to D+ from D on 5/17/2021 due to a significant increase in the growth index, efficiency index and total return index. Operating cash flow increased 157.08% from $21.85M to $56.16M, net income increased 124.82% from -$43.68M to $10.84M, and earnings per share increased from -$0.1723 to $0.0383.
D
Sell
3/11/2021Downgrade
Sotera Health Company (SHC) was downgraded to D from D+ on 3/11/2021 due to a significant decline in the efficiency index, growth index and valuation index. Net income declined 436,900% from $10 to -$43.68M, EBIT declined 60.21% from $93.96M to $37.38M, and operating cash flow declined 52.57% from $46.05M to $21.85M.
Sotera Health Company (SHC) was downgraded to D from D+ on 3/11/2021 due to a significant decline in the efficiency index, growth index and valuation index. Net income declined 436,900% from $10 to -$43.68M, EBIT declined 60.21% from $93.96M to $37.38M, and operating cash flow declined 52.57% from $46.05M to $21.85M.
D
Sell
3/10/2021Upgraded
Sotera Health Company (SHC) was upgraded to D+ from D on 3/10/2021 due to an increase in the total return index and growth index.
Sotera Health Company (SHC) was upgraded to D+ from D on 3/10/2021 due to an increase in the total return index and growth index.
D
Sell
2/19/2021None
Sotera Health Company (SHC) was downgraded to D from U on 02/19/2021.
Sotera Health Company (SHC) was downgraded to D from U on 02/19/2021.
NASDAQ
04/01/2025 4:00PM Eastern
Quotes delayed
